 Lisa Brenner
Concepts (588)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 162 | 2026 | 1642 | 23.470 |
Why?
| | Suicide | 64 | 2026 | 729 | 11.990 |
Why?
| | Brain Injuries, Traumatic | 37 | 2026 | 453 | 10.830 |
Why?
| | Military Personnel | 42 | 2026 | 737 | 8.200 |
Why?
| | Brain Injuries | 43 | 2024 | 507 | 8.080 |
Why?
| | Suicidal Ideation | 45 | 2026 | 583 | 7.240 |
Why?
| | Brain Concussion | 30 | 2025 | 646 | 6.770 |
Why?
| | Stress Disorders, Post-Traumatic | 42 | 2025 | 890 | 6.520 |
Why?
| | Suicide, Attempted | 34 | 2026 | 426 | 6.020 |
Why?
| | United States Department of Veterans Affairs | 55 | 2026 | 779 | 6.000 |
Why?
| | Occupational Therapy | 7 | 2026 | 109 | 5.170 |
Why?
| | Mental Disorders | 24 | 2026 | 1169 | 4.390 |
Why?
| | Microbiota | 14 | 2025 | 730 | 3.820 |
Why?
| | United States | 132 | 2026 | 16123 | 3.720 |
Why?
| | Post-Concussion Syndrome | 10 | 2024 | 184 | 2.770 |
Why?
| | Veterans Health | 13 | 2024 | 190 | 2.670 |
Why?
| | Health Services Accessibility | 9 | 2026 | 1101 | 2.650 |
Why?
| | Humans | 287 | 2026 | 145763 | 2.560 |
Why?
| | Mental Health | 20 | 2025 | 796 | 2.560 |
Why?
| | Adult | 150 | 2026 | 40872 | 2.480 |
Why?
| | Blast Injuries | 9 | 2026 | 62 | 2.330 |
Why?
| | Middle Aged | 124 | 2026 | 36302 | 2.240 |
Why?
| | Male | 168 | 2026 | 73003 | 2.200 |
Why?
| | Gastrointestinal Microbiome | 9 | 2025 | 768 | 2.200 |
Why?
| | Female | 171 | 2026 | 79035 | 2.070 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 171 | 2.020 |
Why?
| | Feces | 5 | 2025 | 496 | 1.790 |
Why?
| | Sleep Initiation and Maintenance Disorders | 8 | 2025 | 196 | 1.730 |
Why?
| | Self-Injurious Behavior | 6 | 2020 | 141 | 1.710 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 508 | 1.670 |
Why?
| | Toxoplasmosis | 7 | 2025 | 43 | 1.660 |
Why?
| | Toxoplasma | 6 | 2025 | 49 | 1.540 |
Why?
| | Activities of Daily Living | 4 | 2025 | 444 | 1.520 |
Why?
| | Firearms | 11 | 2026 | 436 | 1.510 |
Why?
| | Afghan Campaign 2001- | 16 | 2024 | 193 | 1.460 |
Why?
| | Sleep Wake Disorders | 7 | 2026 | 314 | 1.450 |
Why?
| | Psychological Trauma | 3 | 2022 | 57 | 1.410 |
Why?
| | Safety | 3 | 2026 | 358 | 1.340 |
Why?
| | Aged | 57 | 2026 | 26215 | 1.290 |
Why?
| | Brain Injury, Chronic | 4 | 2016 | 25 | 1.260 |
Why?
| | Qualitative Research | 17 | 2026 | 1683 | 1.250 |
Why?
| | Cerebral Palsy | 4 | 2026 | 138 | 1.250 |
Why?
| | Mobile Applications | 2 | 2025 | 199 | 1.240 |
Why?
| | Young Adult | 51 | 2026 | 14251 | 1.210 |
Why?
| | Health Personnel | 3 | 2021 | 757 | 1.200 |
Why?
| | Psychometrics | 11 | 2024 | 731 | 1.190 |
Why?
| | Surveys and Questionnaires | 23 | 2026 | 6085 | 1.170 |
Why?
| | Mental Health Services | 10 | 2024 | 475 | 1.070 |
Why?
| | Healthcare Disparities | 2 | 2025 | 736 | 1.050 |
Why?
| | Risk Factors | 40 | 2026 | 10917 | 1.010 |
Why?
| | Depressive Disorder | 5 | 2024 | 374 | 1.010 |
Why?
| | Inpatients | 7 | 2026 | 553 | 0.990 |
Why?
| | Violence | 6 | 2025 | 280 | 0.980 |
Why?
| | Social Determinants of Health | 2 | 2023 | 309 | 0.980 |
Why?
| | Ambulatory Care | 4 | 2025 | 610 | 0.940 |
Why?
| | Impulsive Behavior | 7 | 2025 | 145 | 0.940 |
Why?
| | Transition to Adult Care | 2 | 2026 | 103 | 0.920 |
Why?
| | Risk Assessment | 22 | 2026 | 3752 | 0.920 |
Why?
| | Hyperbaric Oxygenation | 3 | 2015 | 39 | 0.910 |
Why?
| | Accidents | 1 | 2026 | 46 | 0.910 |
Why?
| | Health Promotion | 5 | 2019 | 775 | 0.910 |
Why?
| | Multiple Trauma | 4 | 2026 | 121 | 0.890 |
Why?
| | Cross-Sectional Studies | 24 | 2025 | 5922 | 0.880 |
Why?
| | Antidepressive Agents | 7 | 2025 | 242 | 0.880 |
Why?
| | Reflex, Startle | 1 | 2025 | 75 | 0.870 |
Why?
| | Pandemics | 5 | 2023 | 1711 | 0.870 |
Why?
| | Aftercare | 3 | 2021 | 222 | 0.870 |
Why?
| | Perception | 3 | 2026 | 378 | 0.860 |
Why?
| | Attitude of Health Personnel | 3 | 2026 | 1197 | 0.850 |
Why?
| | Smartphone | 1 | 2025 | 107 | 0.820 |
Why?
| | Patient Selection | 2 | 2026 | 739 | 0.820 |
Why?
| | Severity of Illness Index | 14 | 2021 | 2933 | 0.810 |
Why?
| | Patient Discharge | 6 | 2025 | 995 | 0.810 |
Why?
| | Specimen Handling | 1 | 2025 | 183 | 0.800 |
Why?
| | Retrospective Studies | 24 | 2026 | 17325 | 0.790 |
Why?
| | DNA, Bacterial | 2 | 2024 | 320 | 0.780 |
Why?
| | Bacteria | 3 | 2025 | 766 | 0.760 |
Why?
| | Rural Population | 2 | 2026 | 661 | 0.760 |
Why?
| | Evidence-Based Medicine | 4 | 2023 | 740 | 0.750 |
Why?
| | Mass Screening | 9 | 2025 | 1361 | 0.740 |
Why?
| | Head Injuries, Closed | 1 | 2022 | 49 | 0.730 |
Why?
| | Physical Therapy Specialty | 1 | 2023 | 55 | 0.710 |
Why?
| | Probiotics | 2 | 2025 | 61 | 0.700 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 1102 | 0.700 |
Why?
| | Residence Characteristics | 1 | 2025 | 375 | 0.690 |
Why?
| | Personality Assessment | 4 | 2017 | 79 | 0.690 |
Why?
| | Drug Overdose | 2 | 2023 | 375 | 0.690 |
Why?
| | Longitudinal Studies | 15 | 2025 | 2967 | 0.690 |
Why?
| | Nutritional Status | 1 | 2024 | 353 | 0.680 |
Why?
| | Sequence Analysis, DNA | 1 | 2024 | 778 | 0.670 |
Why?
| | Psychotherapy | 3 | 2017 | 182 | 0.670 |
Why?
| | Occupational Diseases | 2 | 2020 | 165 | 0.660 |
Why?
| | Clinical Trials as Topic | 1 | 2026 | 1062 | 0.660 |
Why?
| | Cohort Studies | 16 | 2021 | 6032 | 0.650 |
Why?
| | Stroke Rehabilitation | 1 | 2021 | 43 | 0.650 |
Why?
| | Adaptation, Psychological | 8 | 2025 | 719 | 0.640 |
Why?
| | Outpatients | 3 | 2025 | 447 | 0.630 |
Why?
| | Patient Acceptance of Health Care | 5 | 2025 | 883 | 0.630 |
Why?
| | Models, Psychological | 1 | 2022 | 294 | 0.620 |
Why?
| | Disability Evaluation | 6 | 2019 | 311 | 0.610 |
Why?
| | Dysbiosis | 2 | 2018 | 188 | 0.610 |
Why?
| | Spinal Cord Injuries | 2 | 2022 | 235 | 0.610 |
Why?
| | Interviews as Topic | 10 | 2026 | 916 | 0.600 |
Why?
| | Air Pollutants | 1 | 2024 | 406 | 0.600 |
Why?
| | Neuropsychological Tests | 9 | 2024 | 1137 | 0.590 |
Why?
| | Feasibility Studies | 7 | 2025 | 1115 | 0.590 |
Why?
| | Caregivers | 3 | 2026 | 1074 | 0.580 |
Why?
| | Adolescent | 25 | 2026 | 22573 | 0.580 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 13 | 0.560 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 23 | 0.550 |
Why?
| | Pets | 1 | 2018 | 28 | 0.550 |
Why?
| | Antibodies, Protozoan | 5 | 2025 | 41 | 0.550 |
Why?
| | Patient Readmission | 1 | 2024 | 772 | 0.550 |
Why?
| | Death Certificates | 2 | 2023 | 32 | 0.550 |
Why?
| | Depression | 7 | 2025 | 1557 | 0.540 |
Why?
| | Sense of Coherence | 1 | 2018 | 12 | 0.540 |
Why?
| | Hope | 1 | 2018 | 27 | 0.530 |
Why?
| | Wounds, Gunshot | 5 | 2023 | 258 | 0.530 |
Why?
| | Hospitalization | 6 | 2025 | 2460 | 0.530 |
Why?
| | Hospitals, Veterans | 7 | 2022 | 258 | 0.520 |
Why?
| | Child Development | 1 | 2022 | 483 | 0.520 |
Why?
| | Social Support | 6 | 2025 | 651 | 0.520 |
Why?
| | Triage | 1 | 2020 | 250 | 0.520 |
Why?
| | Emotions | 2 | 2025 | 577 | 0.520 |
Why?
| | Risk | 5 | 2023 | 923 | 0.510 |
Why?
| | Drug Packaging | 1 | 2017 | 41 | 0.510 |
Why?
| | Psychotherapy, Group | 1 | 2017 | 79 | 0.490 |
Why?
| | Child Abuse | 1 | 2022 | 553 | 0.490 |
Why?
| | Cognition Disorders | 3 | 2014 | 544 | 0.480 |
Why?
| | Machine Learning | 5 | 2025 | 587 | 0.480 |
Why?
| | Problem Solving | 1 | 2017 | 156 | 0.480 |
Why?
| | Protective Factors | 2 | 2015 | 99 | 0.480 |
Why?
| | Executive Function | 4 | 2017 | 470 | 0.470 |
Why?
| | Parkinson Disease | 1 | 2022 | 601 | 0.470 |
Why?
| | Inflammation | 7 | 2022 | 2883 | 0.470 |
Why?
| | Self Report | 7 | 2026 | 876 | 0.470 |
Why?
| | Home Care Services | 1 | 2019 | 284 | 0.460 |
Why?
| | Headache | 3 | 2022 | 151 | 0.450 |
Why?
| | Postural Balance | 1 | 2018 | 247 | 0.450 |
Why?
| | Sleep Apnea, Obstructive | 3 | 2024 | 303 | 0.450 |
Why?
| | Cause of Death | 2 | 2023 | 471 | 0.450 |
Why?
| | Patient Care Team | 3 | 2024 | 697 | 0.450 |
Why?
| | Sex Factors | 8 | 2025 | 2110 | 0.440 |
Why?
| | Comorbidity | 10 | 2025 | 1662 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 391 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 384 | 0.430 |
Why?
| | Immunoglobulin G | 6 | 2025 | 892 | 0.430 |
Why?
| | Afghanistan | 3 | 2024 | 96 | 0.420 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3416 | 0.420 |
Why?
| | Combat Disorders | 2 | 2017 | 42 | 0.420 |
Why?
| | Natural Language Processing | 2 | 2026 | 106 | 0.410 |
Why?
| | Psychiatric Status Rating Scales | 7 | 2025 | 533 | 0.410 |
Why?
| | Decision Support Techniques | 3 | 2026 | 480 | 0.400 |
Why?
| | Hypertension | 1 | 2022 | 1276 | 0.390 |
Why?
| | Case-Control Studies | 8 | 2022 | 3634 | 0.390 |
Why?
| | Health Planning | 1 | 2013 | 47 | 0.390 |
Why?
| | Iraq | 2 | 2024 | 66 | 0.390 |
Why?
| | Risk Management | 1 | 2014 | 82 | 0.380 |
Why?
| | Neuropsychology | 2 | 2011 | 44 | 0.380 |
Why?
| | Quality Improvement | 2 | 2020 | 1296 | 0.380 |
Why?
| | Recovery of Function | 5 | 2024 | 716 | 0.380 |
Why?
| | Aggression | 5 | 2025 | 180 | 0.380 |
Why?
| | Medication Adherence | 1 | 2017 | 540 | 0.380 |
Why?
| | Prevalence | 11 | 2026 | 2874 | 0.380 |
Why?
| | Anxiety Disorders | 1 | 2016 | 371 | 0.370 |
Why?
| | Observational Studies as Topic | 2 | 2024 | 134 | 0.370 |
Why?
| | Trauma Severity Indices | 5 | 2019 | 115 | 0.370 |
Why?
| | Athletic Injuries | 1 | 2019 | 573 | 0.360 |
Why?
| | Stress, Physiological | 1 | 2015 | 443 | 0.360 |
Why?
| | Interpersonal Relations | 1 | 2015 | 398 | 0.350 |
Why?
| | Health Services Needs and Demand | 2 | 2025 | 280 | 0.350 |
Why?
| | Colorado | 6 | 2024 | 4556 | 0.340 |
Why?
| | Telemedicine | 1 | 2020 | 966 | 0.330 |
Why?
| | Quality of Life | 5 | 2019 | 3210 | 0.330 |
Why?
| | Emergency Service, Hospital | 7 | 2026 | 2383 | 0.320 |
Why?
| | Post-Traumatic Headache | 2 | 2020 | 5 | 0.320 |
Why?
| | Ethanol | 3 | 2024 | 631 | 0.310 |
Why?
| | Bayes Theorem | 2 | 2022 | 421 | 0.310 |
Why?
| | Aged, 80 and over | 7 | 2021 | 8346 | 0.310 |
Why?
| | Socioeconomic Factors | 6 | 2023 | 1327 | 0.310 |
Why?
| | Sex Offenses | 2 | 2023 | 196 | 0.310 |
Why?
| | United States Department of Defense | 2 | 2025 | 24 | 0.300 |
Why?
| | Tryptophan | 3 | 2022 | 182 | 0.300 |
Why?
| | Wounds and Injuries | 1 | 2018 | 962 | 0.300 |
Why?
| | Nervous System Diseases | 2 | 2025 | 286 | 0.290 |
Why?
| | Terminology as Topic | 1 | 2011 | 259 | 0.290 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 337 | 0.280 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2024 | 1751 | 0.280 |
Why?
| | Crisis Intervention | 3 | 2024 | 37 | 0.280 |
Why?
| | Amish | 2 | 2019 | 7 | 0.280 |
Why?
| | Housing | 2 | 2020 | 142 | 0.280 |
Why?
| | Quality of Health Care | 1 | 2013 | 693 | 0.280 |
Why?
| | Public Health | 5 | 2022 | 574 | 0.280 |
Why?
| | Program Evaluation | 3 | 2024 | 944 | 0.270 |
Why?
| | Dizziness | 2 | 2019 | 101 | 0.270 |
Why?
| | Stress, Psychological | 2 | 2020 | 1149 | 0.270 |
Why?
| | Decision Support Systems, Clinical | 2 | 2026 | 273 | 0.270 |
Why?
| | Intention | 1 | 2009 | 186 | 0.260 |
Why?
| | Algorithms | 5 | 2026 | 1850 | 0.260 |
Why?
| | Pregnancy Trimester, First | 2 | 2025 | 139 | 0.260 |
Why?
| | Electronic Health Records | 2 | 2026 | 1202 | 0.250 |
Why?
| | Kynurenine | 3 | 2018 | 114 | 0.250 |
Why?
| | Sleep | 3 | 2024 | 889 | 0.250 |
Why?
| | Neuropsychiatry | 2 | 2020 | 17 | 0.250 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 468 | 0.250 |
Why?
| | Age Factors | 6 | 2024 | 3346 | 0.250 |
Why?
| | Health Behavior | 1 | 2012 | 791 | 0.250 |
Why?
| | Emergency Medical Services | 2 | 2023 | 684 | 0.240 |
Why?
| | Environment, Controlled | 2 | 2016 | 22 | 0.240 |
Why?
| | Oregon | 1 | 2026 | 77 | 0.230 |
Why?
| | Hotlines | 4 | 2024 | 35 | 0.230 |
Why?
| | Factor Analysis, Statistical | 4 | 2024 | 291 | 0.230 |
Why?
| | New Mexico | 1 | 2026 | 99 | 0.230 |
Why?
| | Central Nervous System | 2 | 2025 | 282 | 0.230 |
Why?
| | Time Factors | 7 | 2019 | 7133 | 0.230 |
Why?
| | Prospective Studies | 10 | 2025 | 8075 | 0.230 |
Why?
| | Follow-Up Studies | 5 | 2022 | 5428 | 0.230 |
Why?
| | Treatment Outcome | 11 | 2022 | 11793 | 0.220 |
Why?
| | Rehabilitation Research | 1 | 2025 | 7 | 0.220 |
Why?
| | Rehabilitation Centers | 2 | 2024 | 39 | 0.220 |
Why?
| | Fentanyl | 1 | 2026 | 128 | 0.220 |
Why?
| | Neurological Rehabilitation | 1 | 2025 | 13 | 0.220 |
Why?
| | Common Data Elements | 1 | 2025 | 18 | 0.220 |
Why?
| | Motivation | 1 | 2009 | 602 | 0.220 |
Why?
| | Drug Storage | 1 | 2025 | 53 | 0.210 |
Why?
| | Social Participation | 1 | 2025 | 29 | 0.210 |
Why?
| | tau Proteins | 1 | 2025 | 105 | 0.210 |
Why?
| | Social Environment | 1 | 2026 | 252 | 0.210 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 147 | 0.210 |
Why?
| | Delay Discounting | 1 | 2024 | 29 | 0.210 |
Why?
| | Policy | 2 | 2022 | 149 | 0.210 |
Why?
| | Logistic Models | 7 | 2025 | 2139 | 0.210 |
Why?
| | Lomustine | 1 | 2024 | 17 | 0.210 |
Why?
| | Affect | 2 | 2018 | 321 | 0.210 |
Why?
| | Primary Health Care | 2 | 2025 | 1737 | 0.210 |
Why?
| | Complementary Therapies | 2 | 2016 | 96 | 0.210 |
Why?
| | Decision Making | 3 | 2024 | 982 | 0.210 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 40 | 0.200 |
Why?
| | Mouth | 1 | 2024 | 86 | 0.200 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 2000 | 0.200 |
Why?
| | Metals, Heavy | 1 | 2024 | 31 | 0.200 |
Why?
| | Sex Distribution | 2 | 2023 | 388 | 0.200 |
Why?
| | Anxiety | 4 | 2025 | 1122 | 0.200 |
Why?
| | Pesticides | 1 | 2024 | 59 | 0.200 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.200 |
Why?
| | Wildfires | 1 | 2024 | 42 | 0.190 |
Why?
| | Prognosis | 3 | 2024 | 4329 | 0.190 |
Why?
| | Global Burden of Disease | 1 | 2023 | 24 | 0.190 |
Why?
| | Psychiatric Department, Hospital | 2 | 2014 | 12 | 0.190 |
Why?
| | Clinical Protocols | 2 | 2015 | 280 | 0.190 |
Why?
| | Abruptio Placentae | 1 | 2022 | 6 | 0.190 |
Why?
| | Prednisone | 1 | 2024 | 226 | 0.190 |
Why?
| | Transportation of Patients | 1 | 2023 | 65 | 0.190 |
Why?
| | Rats, Sprague-Dawley | 2 | 2025 | 2525 | 0.190 |
Why?
| | Disasters | 1 | 2024 | 100 | 0.190 |
Why?
| | Disaster Planning | 1 | 2024 | 103 | 0.190 |
Why?
| | Interview, Psychological | 2 | 2015 | 95 | 0.180 |
Why?
| | Ohio | 1 | 2022 | 146 | 0.180 |
Why?
| | Pharmacogenomic Testing | 1 | 2022 | 63 | 0.180 |
Why?
| | Schizophrenia | 2 | 2016 | 464 | 0.170 |
Why?
| | Biomarkers | 4 | 2026 | 4302 | 0.170 |
Why?
| | Neopterin | 2 | 2022 | 13 | 0.170 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 66 | 0.170 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 173 | 0.170 |
Why?
| | Subacute Care | 1 | 2022 | 84 | 0.170 |
Why?
| | Incidence | 6 | 2019 | 2933 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1420 | 0.170 |
Why?
| | Physician-Patient Relations | 2 | 2025 | 588 | 0.170 |
Why?
| | Hepatic Encephalopathy | 1 | 2021 | 25 | 0.160 |
Why?
| | Guideline Adherence | 1 | 2025 | 587 | 0.160 |
Why?
| | Drug Interactions | 1 | 2022 | 405 | 0.160 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 534 | 0.160 |
Why?
| | Skin | 2 | 2023 | 754 | 0.160 |
Why?
| | Cost of Illness | 1 | 2023 | 324 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2025 | 440 | 0.160 |
Why?
| | Pilot Projects | 5 | 2024 | 1897 | 0.160 |
Why?
| | Frailty | 1 | 2024 | 205 | 0.160 |
Why?
| | Burns | 1 | 2025 | 374 | 0.160 |
Why?
| | Skilled Nursing Facilities | 1 | 2022 | 152 | 0.160 |
Why?
| | Parenting | 1 | 2024 | 319 | 0.160 |
Why?
| | Anger | 3 | 2021 | 61 | 0.160 |
Why?
| | Air Pollution | 1 | 2024 | 315 | 0.160 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2016 | 232 | 0.160 |
Why?
| | Hawaii | 3 | 2026 | 37 | 0.160 |
Why?
| | Databases, Factual | 2 | 2026 | 1491 | 0.160 |
Why?
| | Proteome | 1 | 2025 | 513 | 0.160 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.150 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2021 | 96 | 0.150 |
Why?
| | HIV Infections | 1 | 2015 | 3195 | 0.150 |
Why?
| | Rats | 2 | 2025 | 5585 | 0.150 |
Why?
| | Sex Characteristics | 1 | 2025 | 789 | 0.150 |
Why?
| | Hyperacusis | 1 | 2019 | 9 | 0.150 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 56 | 0.150 |
Why?
| | Photophobia | 1 | 2019 | 13 | 0.150 |
Why?
| | Hypesthesia | 1 | 2019 | 21 | 0.150 |
Why?
| | Environment Design | 2 | 2016 | 27 | 0.150 |
Why?
| | Survival Analysis | 3 | 2011 | 1378 | 0.150 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 190 | 0.150 |
Why?
| | Communicable Diseases | 1 | 2022 | 166 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2025 | 603 | 0.150 |
Why?
| | Paresis | 1 | 2019 | 30 | 0.150 |
Why?
| | Periodontitis | 1 | 2020 | 55 | 0.150 |
Why?
| | Arm Injuries | 1 | 2019 | 25 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2024 | 578 | 0.150 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 18 | 0.150 |
Why?
| | Morals | 1 | 2020 | 79 | 0.150 |
Why?
| | Hippocampus | 1 | 2025 | 973 | 0.140 |
Why?
| | Odds Ratio | 5 | 2016 | 1083 | 0.140 |
Why?
| | Environmental Microbiology | 1 | 2019 | 47 | 0.140 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 364 | 0.140 |
Why?
| | Occupational Injuries | 1 | 2019 | 49 | 0.140 |
Why?
| | Medical Staff, Hospital | 1 | 2019 | 80 | 0.140 |
Why?
| | Alcoholism | 2 | 2024 | 826 | 0.140 |
Why?
| | Patient-Centered Care | 1 | 2024 | 547 | 0.140 |
Why?
| | Arm | 1 | 2019 | 110 | 0.140 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 287 | 0.140 |
Why?
| | Delirium | 2 | 2011 | 105 | 0.140 |
Why?
| | Women's Health | 1 | 2021 | 316 | 0.140 |
Why?
| | Premature Birth | 1 | 2022 | 390 | 0.140 |
Why?
| | Health Services Research | 1 | 2021 | 391 | 0.140 |
Why?
| | Diet | 2 | 2023 | 1278 | 0.140 |
Why?
| | Fatigue | 2 | 2018 | 365 | 0.140 |
Why?
| | Psychotherapy, Brief | 1 | 2018 | 41 | 0.140 |
Why?
| | Food Supply | 1 | 2019 | 89 | 0.140 |
Why?
| | Cross-Over Studies | 2 | 2018 | 610 | 0.130 |
Why?
| | Reproductive Health | 3 | 2024 | 91 | 0.130 |
Why?
| | Adiponectin | 1 | 2020 | 242 | 0.130 |
Why?
| | Phenylalanine | 1 | 2018 | 69 | 0.130 |
Why?
| | Child | 5 | 2024 | 22739 | 0.130 |
Why?
| | Tyrosine | 1 | 2018 | 217 | 0.130 |
Why?
| | Confidence Intervals | 3 | 2016 | 330 | 0.130 |
Why?
| | Dogs | 1 | 2018 | 478 | 0.130 |
Why?
| | Prebiotics | 1 | 2017 | 28 | 0.120 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 336 | 0.120 |
Why?
| | Gliadin | 1 | 2016 | 13 | 0.120 |
Why?
| | Amygdala | 2 | 2017 | 200 | 0.120 |
Why?
| | Housing, Animal | 1 | 2016 | 46 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2017 | 4568 | 0.120 |
Why?
| | Social Work, Psychiatric | 1 | 2015 | 3 | 0.120 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 337 | 0.110 |
Why?
| | Community Mental Health Centers | 1 | 2015 | 14 | 0.110 |
Why?
| | Immunomodulation | 1 | 2016 | 99 | 0.110 |
Why?
| | Animals | 7 | 2025 | 38097 | 0.110 |
Why?
| | Neuroimaging | 2 | 2017 | 300 | 0.110 |
Why?
| | Obesity | 2 | 2019 | 3118 | 0.110 |
Why?
| | Medical Records | 1 | 2016 | 192 | 0.110 |
Why?
| | Actigraphy | 1 | 2016 | 148 | 0.110 |
Why?
| | Delivery of Health Care | 4 | 2023 | 947 | 0.110 |
Why?
| | Prescription Drug Misuse | 1 | 2015 | 53 | 0.110 |
Why?
| | Counseling | 2 | 2023 | 401 | 0.110 |
Why?
| | Health Status Indicators | 2 | 2012 | 167 | 0.110 |
Why?
| | Israel | 2 | 2025 | 46 | 0.110 |
Why?
| | Propylamines | 1 | 2014 | 11 | 0.110 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2014 | 14 | 0.110 |
Why?
| | Guam | 2 | 2025 | 17 | 0.100 |
Why?
| | Needs Assessment | 2 | 2024 | 403 | 0.100 |
Why?
| | Thalamus | 1 | 2015 | 129 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1154 | 0.100 |
Why?
| | Mood Disorders | 1 | 2015 | 144 | 0.100 |
Why?
| | Cross-Cultural Comparison | 1 | 2014 | 84 | 0.100 |
Why?
| | Forecasting | 1 | 2016 | 390 | 0.100 |
Why?
| | Genes, p53 | 1 | 1993 | 67 | 0.100 |
Why?
| | Biomedical Research | 1 | 2020 | 719 | 0.100 |
Why?
| | Cerebellum | 1 | 2015 | 224 | 0.100 |
Why?
| | Analgesics | 1 | 2015 | 231 | 0.100 |
Why?
| | Forensic Psychiatry | 1 | 2013 | 28 | 0.100 |
Why?
| | Self Concept | 1 | 2015 | 254 | 0.100 |
Why?
| | Australia | 1 | 2014 | 291 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2011 | 528 | 0.100 |
Why?
| | Burnout, Professional | 1 | 2020 | 488 | 0.100 |
Why?
| | Seroepidemiologic Studies | 3 | 2019 | 171 | 0.100 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 549 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 712 | 0.090 |
Why?
| | Stress Disorders, Traumatic | 1 | 2013 | 25 | 0.090 |
Why?
| | Linear Models | 3 | 2010 | 849 | 0.090 |
Why?
| | Employment | 1 | 2014 | 184 | 0.090 |
Why?
| | Sex | 1 | 2012 | 5 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1547 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 750 | 0.090 |
Why?
| | Football | 1 | 2013 | 89 | 0.090 |
Why?
| | Computer Communication Networks | 1 | 2012 | 32 | 0.090 |
Why?
| | Brain | 4 | 2021 | 2969 | 0.090 |
Why?
| | Advisory Committees | 1 | 2013 | 229 | 0.090 |
Why?
| | Task Performance and Analysis | 2 | 2017 | 198 | 0.090 |
Why?
| | Therapy, Computer-Assisted | 1 | 2012 | 63 | 0.090 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 428 | 0.090 |
Why?
| | Infant | 2 | 2022 | 10090 | 0.080 |
Why?
| | Information Dissemination | 1 | 2013 | 224 | 0.080 |
Why?
| | Signal Transduction | 1 | 2025 | 5223 | 0.080 |
Why?
| | Social Stigma | 1 | 2013 | 173 | 0.080 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.080 |
Why?
| | Consciousness Disorders | 1 | 2011 | 25 | 0.080 |
Why?
| | Interprofessional Relations | 1 | 2013 | 276 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 1993 | 474 | 0.080 |
Why?
| | Life Change Events | 1 | 2012 | 147 | 0.080 |
Why?
| | Walking | 1 | 2015 | 545 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 69 | 0.080 |
Why?
| | Pregnancy | 4 | 2025 | 7215 | 0.080 |
Why?
| | Inservice Training | 1 | 2011 | 118 | 0.080 |
Why?
| | Research | 1 | 2013 | 431 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2123 | 0.080 |
Why?
| | Health Policy | 1 | 2013 | 400 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 1048 | 0.080 |
Why?
| | Health Plan Implementation | 1 | 2011 | 141 | 0.080 |
Why?
| | Life Style | 1 | 2012 | 486 | 0.080 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 156 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 430 | 0.080 |
Why?
| | Multiple Sclerosis | 1 | 2015 | 489 | 0.080 |
Why?
| | Irritable Mood | 2 | 2021 | 50 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2011 | 1300 | 0.080 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 201 | 0.080 |
Why?
| | Explosions | 1 | 2009 | 14 | 0.080 |
Why?
| | Religion and Psychology | 1 | 2009 | 27 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1512 | 0.070 |
Why?
| | HIV-1 | 1 | 2015 | 908 | 0.070 |
Why?
| | Elective Surgical Procedures | 1 | 2011 | 203 | 0.070 |
Why?
| | Affective Symptoms | 1 | 2009 | 53 | 0.070 |
Why?
| | Data Collection | 1 | 2012 | 643 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2014 | 777 | 0.070 |
Why?
| | Neurologic Examination | 1 | 2009 | 132 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1993 | 641 | 0.070 |
Why?
| | Hypogonadism | 1 | 2009 | 93 | 0.070 |
Why?
| | Cooperative Behavior | 1 | 2011 | 463 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1330 | 0.070 |
Why?
| | Population Surveillance | 1 | 2011 | 484 | 0.070 |
Why?
| | Brain Mapping | 1 | 2011 | 542 | 0.070 |
Why?
| | Alcohol Drinking | 1 | 2014 | 843 | 0.060 |
Why?
| | Resilience, Psychological | 1 | 2009 | 150 | 0.060 |
Why?
| | Language Disorders | 1 | 2007 | 28 | 0.060 |
Why?
| | Glasgow Coma Scale | 3 | 2014 | 218 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 849 | 0.060 |
Why?
| | Claudin-3 | 1 | 2026 | 3 | 0.060 |
Why?
| | Puerto Rico | 1 | 2026 | 63 | 0.060 |
Why?
| | Healthy Volunteers | 2 | 2018 | 219 | 0.060 |
Why?
| | Psychological Tests | 1 | 2007 | 130 | 0.060 |
Why?
| | Aging | 1 | 2017 | 1973 | 0.060 |
Why?
| | Orthotic Devices | 1 | 2025 | 27 | 0.060 |
Why?
| | Permeability | 1 | 2026 | 169 | 0.060 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2026 | 79 | 0.060 |
Why?
| | American Samoa | 1 | 2025 | 7 | 0.060 |
Why?
| | Micronesia | 1 | 2025 | 8 | 0.060 |
Why?
| | Hostility | 1 | 2025 | 16 | 0.060 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2025 | 6 | 0.060 |
Why?
| | Firefighters | 1 | 2026 | 47 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 45 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 122 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 79 | 0.050 |
Why?
| | Testosterone | 1 | 2009 | 416 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2025 | 15 | 0.050 |
Why?
| | Terrorism | 1 | 2024 | 27 | 0.050 |
Why?
| | Reproductive Health Services | 1 | 2024 | 19 | 0.050 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2024 | 67 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3915 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2024 | 78 | 0.050 |
Why?
| | Documentation | 1 | 2026 | 199 | 0.050 |
Why?
| | Warfare | 1 | 2025 | 99 | 0.050 |
Why?
| | Social Change | 1 | 2024 | 16 | 0.050 |
Why?
| | Treatment Adherence and Compliance | 1 | 2024 | 27 | 0.050 |
Why?
| | Comparative Effectiveness Research | 1 | 2025 | 169 | 0.050 |
Why?
| | Length of Stay | 1 | 2009 | 1350 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2024 | 160 | 0.050 |
Why?
| | Asphyxia | 1 | 2023 | 24 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 219 | 0.050 |
Why?
| | Friends | 1 | 2023 | 56 | 0.050 |
Why?
| | Choice Behavior | 1 | 2024 | 180 | 0.050 |
Why?
| | Practice Guidelines as Topic | 2 | 2026 | 1582 | 0.050 |
Why?
| | Cognition | 2 | 2022 | 1271 | 0.050 |
Why?
| | Fertility | 1 | 2024 | 174 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 265 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1969 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 867 | 0.050 |
Why?
| | Stillbirth | 1 | 2022 | 82 | 0.040 |
Why?
| | Public Opinion | 1 | 2022 | 62 | 0.040 |
Why?
| | Remission Induction | 1 | 2022 | 306 | 0.040 |
Why?
| | Ownership | 1 | 2022 | 115 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2023 | 344 | 0.040 |
Why?
| | Social Justice | 1 | 2022 | 81 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2022 | 175 | 0.040 |
Why?
| | Research Report | 1 | 2021 | 86 | 0.040 |
Why?
| | Nursing Homes | 1 | 2022 | 174 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 40 | 0.040 |
Why?
| | Lithium Compounds | 1 | 2019 | 11 | 0.040 |
Why?
| | Internet | 1 | 2024 | 693 | 0.040 |
Why?
| | Patient Compliance | 1 | 2024 | 588 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2011 | 2977 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2015 | 2064 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 81 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2393 | 0.040 |
Why?
| | September 11 Terrorist Attacks | 1 | 2019 | 31 | 0.040 |
Why?
| | Retirement | 1 | 2019 | 35 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 364 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2865 | 0.030 |
Why?
| | Research Design | 2 | 2015 | 1139 | 0.030 |
Why?
| | Serologic Tests | 1 | 2018 | 54 | 0.030 |
Why?
| | Attitude | 1 | 2020 | 259 | 0.030 |
Why?
| | Proteomics | 1 | 2025 | 1188 | 0.030 |
Why?
| | Ketamine | 1 | 2019 | 137 | 0.030 |
Why?
| | Wakefulness | 1 | 2019 | 170 | 0.030 |
Why?
| | Patient Preference | 1 | 2020 | 223 | 0.030 |
Why?
| | Germany | 1 | 2018 | 138 | 0.030 |
Why?
| | Memory Disorders | 1 | 2019 | 197 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2019 | 279 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 693 | 0.030 |
Why?
| | Seasons | 1 | 2020 | 538 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 182 | 0.030 |
Why?
| | War-Related Injuries | 1 | 2017 | 46 | 0.030 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2016 | 57 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 461 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2019 | 296 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1270 | 0.030 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 1996 | 19 | 0.030 |
Why?
| | Dopamine Antagonists | 1 | 1996 | 26 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 868 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 592 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1372 | 0.030 |
Why?
| | Placenta | 1 | 2022 | 787 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 1996 | 104 | 0.030 |
Why?
| | Dopamine | 1 | 2018 | 295 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 1996 | 138 | 0.030 |
Why?
| | Environment | 1 | 2017 | 293 | 0.030 |
Why?
| | Psychological Techniques | 1 | 2014 | 8 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1478 | 0.030 |
Why?
| | Poverty | 1 | 2019 | 529 | 0.030 |
Why?
| | Pyrrolidines | 1 | 1996 | 125 | 0.030 |
Why?
| | Reward | 1 | 2017 | 248 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2015 | 85 | 0.030 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2014 | 8 | 0.030 |
Why?
| | Benzamides | 1 | 1996 | 226 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 972 | 0.030 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 161 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 205 | 0.030 |
Why?
| | Florida | 1 | 2014 | 117 | 0.030 |
Why?
| | Risk-Taking | 1 | 2017 | 323 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 343 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 1996 | 211 | 0.020 |
Why?
| | Health Surveys | 1 | 2015 | 520 | 0.020 |
Why?
| | Drug Resistance | 1 | 1993 | 145 | 0.020 |
Why?
| | Piperazines | 1 | 1996 | 375 | 0.020 |
Why?
| | Personality | 1 | 2014 | 129 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1430 | 0.020 |
Why?
| | Suramin | 1 | 2012 | 8 | 0.020 |
Why?
| | Exercise Test | 1 | 2015 | 630 | 0.020 |
Why?
| | Leukopenia | 1 | 2012 | 33 | 0.020 |
Why?
| | Pain Measurement | 1 | 2015 | 562 | 0.020 |
Why?
| | Focus Groups | 1 | 2015 | 572 | 0.020 |
Why?
| | Genetic Vectors | 1 | 1993 | 335 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1993 | 887 | 0.020 |
Why?
| | Taxoids | 1 | 2012 | 114 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2012 | 94 | 0.020 |
Why?
| | Health Priorities | 1 | 2012 | 41 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2012 | 2028 | 0.020 |
Why?
| | Nausea | 1 | 2012 | 112 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2012 | 283 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3170 | 0.020 |
Why?
| | Ethical Review | 1 | 2011 | 3 | 0.020 |
Why?
| | Wheelchairs | 1 | 2011 | 16 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 259 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6464 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 404 | 0.020 |
Why?
| | Medical History Taking | 1 | 2010 | 117 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2011 | 61 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 770 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 219 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 782 | 0.020 |
Why?
| | Base Sequence | 1 | 1993 | 2171 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 798 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 688 | 0.020 |
Why?
| | Pain | 1 | 2015 | 791 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2883 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 61 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2011 | 599 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2011 | 240 | 0.020 |
Why?
| | Dementia | 1 | 2013 | 328 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 123 | 0.020 |
Why?
| | Self Efficacy | 1 | 2012 | 413 | 0.020 |
Why?
| | Head and Neck Neoplasms | 1 | 1993 | 561 | 0.020 |
Why?
| | Preoperative Care | 1 | 2011 | 380 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 618 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 835 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 2094 | 0.010 |
Why?
| | Cell Differentiation | 1 | 1993 | 2050 | 0.010 |
Why?
| | Mice | 1 | 2016 | 18355 | 0.010 |
Why?
| | Receptors, Dopamine D2 | 1 | 1996 | 93 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 1996 | 428 | 0.010 |
Why?
| | Corpus Striatum | 1 | 1996 | 179 | 0.010 |
Why?
| | Contrast Media | 1 | 1996 | 497 | 0.010 |
Why?
|
|
Brenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|